Zafirlukast

Chronic Conditions

Zafirlukast

Generic For Accolate®

starting at $59.99

Zafirlukast is used for the chronic treatment of asthma when other agents have failed to control persistent asthma alone. This medication is suitable for individuals that have already been taking zafirlukast as prescribed by an authorized healthcare provider.

Used as a maintenance therapy for persistent asthma that cannot be controlled with an inhaled corticosteroid

Works by decreasing inflammation in the airways, making it easier to breathe

To be taken on an empty stomach either 1 hour before or 2 hours after meals

Must be taken as prescribed for at least 1 to 2 months before assessing efficacy

Refill

HSA/FSA Eligible

H&P Certification

Tell us about yourself.

“You need to carefully review and make sure you can agree to each statement. If there are questions, a doctor will be in touch after checkout.”

Zafirlukast

By clicking the “I Agree” button below, you certify under penalty of perjury that the following statements are true and correct and understand that a medical provider will rely on the truthfulness of your statements when determining whether a prescription is warranted and appropriate.

I agree that I:

am 18 years or older
have not had a hypersensitivity reaction to zafirlukast or any component of the formulation

have a diagnosis of asthma and have already been taking zafirlukast as prescribed by an authorized healthcare provider
Am taking zafirlukast as prescribed for my own personal use

do not have hepatic (liver) impairment including hepatic cirrhosis
am not pregnant or breastfeeding
do not have phenylketonuria (PKU)
understand zafirlukast must be taken daily and is not for use of acute asthma attacks
understand severe hepatic adverse events (including hepatitis, hyperbilirubinemia, and hepatic failure) have been reported with use of zafirlukast and to be alert for and immediately report symptoms of anorexia, right upper quadrant abdominal pain, and nausea to my primary care provider
understand postmarketing reports of behavioral changes (ie, depression, insomnia) have been noted with zafirlukast and will report neuropsychiatric symptoms/events during therapy to my primary care provider
understand zafirlukast is not approved for use in the reversal of bronchospasm in acute asthma attacks, including status asthmaticus; therapy can be continued during acute exacerbations of asthma
understand concomitant use of zafirlukast with warfarin results in a clinically significant increase in INR
have already been taking the initial dose (zafirlukast 10 mg) or have been previously prescribed zafirlukast 20 mg if selecting zafirlukast 20 mg
understand zafirlukast is associated with an increased incidence of respiratory tract infections, particularly in patients aged 55 or older that concomitantly take inhaled corticosteroids
Will not take nor intend to take the following concurrently with zafirlukast due to severe or major drug-drug interactions: loxapine, systemic erythromycin, phenytoin, theophylline, tolbutamide, warfarin

understand this is not a comprehensive list of severe or major drug interactions and I can find more information regarding drug-drug interactions at https://www.drugs.com/drug_interactions.html

understand this is not a comprehensive list of precautions, risks, side effects, or details about taking this medication
understand that only major drug interactions are listed and have not been reviewed against the other medications, supplements, or herbal products I may be taking unless also filled by TelyRx

understand that TelyRx LLC does not provide medical care and the providers who use TelyRx to provide telehealth services (“Telehealth Providers”) should not replace your primary provider.
understand that the Telehealth Providers are not able to: (1) monitor ongoing health or lab values for side effects or efficacy, (2) observe how you (or your pet) tolerate any prescribed treatment, or (3) determine if the prescribed treatment is working as intended and assume any risks associated with this modality of care and waive any claim I may have in the future against TelyRx and/or the Telehealth Providers.
understand that by using this site, I have created a patient-client-doctor relationship and I am being directed by the Telehealth Providers to consult my primary provider soon after beginning any treatment prescribed by the Telehealth Providers.
understand that this is a supplemental mode of care for your convenience and the Telehealth Providers are not to be used, or relied on, as a replacement for in-person follow-up visits or interactions with your primary provider.

I agree that all statements above are true and my physician visit is complete.

Cancel

Web-form is not active.

Skip to the end of the images gallery

For illustration purposes only. Product appearance may vary based on manufacturer availability.

Skip to the beginning of the images gallery

Zafirlukast Medication Description
Zafirlukast is an oral leukotriene receptor antagonist used as a maintenance treatment for persistent asthma that is not adequately controlled with inhaled corticosteroids alone. It works by blocking leukotrienes, inflammatory chemicals in the body that cause airway tightening, swelling, and mucus production. By reducing airway inflammation, Zafirlukast helps improve breathing, decrease asthma symptoms, and reduce the need for rescue inhalers. This medication is not intended for acute asthma attacks but rather for long-term management of chronic asthma.

Usage Instructions
- Used as a maintenance therapy for persistent asthma
- Taken on an empty stomach, either 1 hour before or 2 hours after meals
- Typically must be taken consistently as prescribed for at least 1 to 2 months before assessing effectiveness
- Not for sudden asthma attacks or emergency relief
Warnings & Precautions
- May cause side effects such as headache, nausea, diarrhea, or infection risk
- Rare but serious side effects may include liver dysfunction or mood changes; liver function monitoring may be recommended
- Inform your healthcare provider if you have liver disease or take other medications that may interact with Zafirlukast
- Continue using inhaled corticosteroids unless instructed otherwise by your provider
- Do not stop or change dosing without consulting your healthcare professional
Zafirlukast Side Effects

Zafirlukast side effects may include: headache, dizziness, abdominal pain, diarrhea, nausea, vomiting, dyspepsia, back pain, weakness, depression, insomnia, abnormal dreams, hallucinations, elevation in liver enzymes; respiratory tract infection in patients >55 years old with coadministration of inhaled corticosteroids.
Consumer Information Use and Disclaimer

This information should not be used to decide whether or not to take this medicine or any other medicine. Only a healthcare provider has the knowledge and training to decide which medicines are right for you. TelyRx does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a limited summary of general information about the medicine’s uses from the patient education materials and is not intended to be comprehensive. This limited summary does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this medicine. This information is not intended to provide medical advice, diagnosis or treatment and does not replace information you may receive from your healthcare provider. For a more detailed summary of information about the risks and benefits of using this medicine, please review the entire patient education information you receive with the medication.